State-Level Prevalence, Utilization and Cost Varies Widely among Medicare Beneficiaries with Parkinson's Disease

被引：0
|
作者：
Fullard, Michelle [1 ]
Mantri, Sneha [1 ]
Willis, Allison [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
ANNALS OF NEUROLOGY | 2018年 / 84卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S215
引用
收藏
页码：S89 / S90
页数：2
相关论文
共 50 条
  • [41] State-Level Hypertension Prevalence and Control Among Adults in the US
    He, Siran
    Park, Soyoun
    Fujii, Yui
    Pierce, Samantha L.
    Kraus, Emily M.
    Wall, Hilary K.
    Therrien, Nicole L.
    Jackson, Sandra L.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2024, 66 (01) : 46 - 54
  • [42] Geographic variation in the prevalence of macular disease among elderly Medicare beneficiaries in Kansas
    Holcomb, CA
    Lin, MC
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2005, 95 (01) : 75 - 77
  • [43] Healthcare Utilization Among Medicare Beneficiaries with Coal Worker's Pneumoconiosis in the US
    Arif, A.
    Patel, R.
    Owusu, C.
    Paul, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [44] Direct costs and survival of medicare beneficiaries with early and advanced parkinson's disease
    Kaltenboeck, A.
    Johnson, S. J.
    Davis, M. R.
    Birnbaum, H. G.
    Carroll, C. A.
    Tarrants, M. L.
    Siderowf, A. D.
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (04) : 321 - 326
  • [45] Treatment Patterns and Healthcare Resource Use in Medicare Beneficiaries with Parkinson's Disease
    Song, Yan
    Jian-Yu, E.
    Guo, Tracy
    Sasane, Rahul
    Arcona, Steve
    Keshava, Nirmal
    Wu, Eric
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2023, 15 : 631 - 643
  • [46] Prevalence of Biologic Utilization Over Calendar Time Among Medicare Beneficiaries with Rheumatoid Arthritis.
    Zhang, Jie
    Xie, Fenglong
    Delzell, Elizabeth S.
    Chen, Lang
    Lewis, James
    Haynes, Kevin
    Saag, Kenneth G.
    Curtis, Jeffrey
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S163 - S163
  • [47] Comparison of Pimavanserin Versus Quetiapine for Hospitalization and Mortality Risk Among Medicare Beneficiaries with Parkinson's Disease Psychosis
    Alipour-Haris, Golnoosh
    Armstrong, Melissa J.
    Okun, Michael
    Brown, Joshua D.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (03): : 406 - 414
  • [48] Mortality Among Parkinson's Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare Beneficiaries
    Mosholder, Andrew D.
    Ma, Yong
    Akhtar, Sandia
    Podskalny, Gerald D.
    Feng, Yuhui
    Lyu, Hai
    Liao, Jiemin
    Wei, Yuqin
    Wernecke, Michael
    Leishear, Kira
    Nelson, Lorene M.
    MaCurdy, Thomas E.
    Kelman, Jeffrey A.
    Graham, David J.
    AMERICAN JOURNAL OF PSYCHIATRY, 2022, 179 (08): : 553 - 561
  • [49] Reader Response: Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries
    You, Michelle
    Grobois, Lauren
    Etienne, Mill
    NEUROLOGY, 2024, 103 (07)
  • [50] Author Response: Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries
    Krzyzanowski, Brittany
    NEUROLOGY, 2024, 103 (07)
12345